Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+52.4% YoY

Gross Profit

$3M62.6% margin

Operating Income

-$4M-80.8% margin

Net Income

-$4M-82.8% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$880,000

Balance Sheet

Total Assets

$60M

Total Liabilities

$17M

Stockholders' Equity

$43M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+52.4%
Gross Profit	$3M	$2M	+42.1%
Operating Income	-$4M	-$3M	-23.4%
Net Income	-$4M	-$4M	-15.0%

Revenue Segments

Biologics And Drug Delivery

$2M23%

Functional Neurosurgery Navigation and Therapy

$2M21%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M17%

Biologics And Drug Delivery - Disposable Products

$1M12%

Biologics And Drug Delivery - Services

$1M11%

Capital Equipment And Software

$619,0006%

Capital Equipment And Software - Systems and Software Products

$434,0004%

Functional Neurosurgery Navigation and Therapy - Services

$375,0004%

Capital Equipment And Software - Services

$185,0002%